je.st
news
Home
› AmpliPhi Biosciences' CEO To Discuss Novel Approaches To Fighting Drug-Resistant Pathogens In Panel At BIO International
AmpliPhi Biosciences' CEO To Discuss Novel Approaches To Fighting Drug-Resistant Pathogens In Panel At BIO International
2016-06-01 05:37:22| drugdiscoveryonline Home Page
AmpliPhi Biosciences Corporation , a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, recently announced that M. Scott Salka, AmpliPhi’s Chief Executive Officer, will participate in a panel discussion at this year’s BIO International Convention
Tags: international
panel
discuss
bio
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||